Evaluation of the Edwards Lifesciences SAPIEN transcatheter heart valve

References

• Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368(9540):1005-11
   PubMed Web of Science ®Google Scholar
• Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24(13):1231-43
   PubMed Web of Science ®Google Scholar
• Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology, European Association for Cardio-Thoracic Surgery. Vahanian A, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33(19):2451-96
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363(17):1597-607
   PubMed Web of Science ®Google Scholar
• Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000;356(9239):1403-5
   PubMed Web of Science ®Google Scholar
• Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106(24):3006-8
   PubMed Web of Science ®Google Scholar
• Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006;47(6):1214-23
   PubMed Web of Science ®Google Scholar
• Walther T, Kasimir MT, Doss M, et al. One-year interim follow-up results of the TRAVERCE trial: the initial feasibility study for trans-apical aortic-valve implantation. Eur J Cardiothorac Surg 2011;39(4):532-7
   PubMedGoogle Scholar
• Kodali SK, O’Neill WW, Moses JW, et al. Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial). Am J Cardiol 2011;107(7):1058-64
   PubMedGoogle Scholar
• Svensson LG, Dewey T, Kapadia S, et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 2008;86(1):46-54; discussion 54-45
   Google Scholar
• Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012;366(18):1686-95
   PubMed Web of Science ®Google Scholar
• Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;366(18):1696-704
   PubMed Web of Science ®Google Scholar
• Leon MB. A randomized evaluation of the SAPIEN XT transcatheter valve system in patients with Aortic stenosis who are not candidates for surgery: PARTNER II, inoperable cohort. In: Annual Meeting of the American College of Cardiology. San-Francisco, USA; 2013
   Google Scholar
• Lefevre T, Kappetein AP, Wolner E, et al. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 2011;32(2):148-57
   PubMedGoogle Scholar
• Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010;122(1):62-9
   PubMed Web of Science ®Google Scholar
• Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011;124(4):425-33
   PubMed Web of Science ®Google Scholar
• Windecker S. One-Year outcome from the SOURCE XT post-approval study. In: Euro-PCR. Paris, France; 2013
   Google Scholar
• Mack MJ, Brennan JM, Brindis R, et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA 2013;310(19):2069-77
   PubMed Web of Science ®Google Scholar
• Arnold SV, Spertus JA, Lei Y, et al. How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial. Circ Cardiovasc Qual Outcomes 2013;6(5):591-7
   PubMed Web of Science ®Google Scholar
• Nirat Beohar VT, Herrmann H, Mack M, et al. Predictors of ‘Futility’ after transcatheter aortic valve replacement: an analysis from the PARTNER randomized trial. In: Transcatheter cardiovascular therapeutics (TCT) conference. Miami Beach.FL, USA;2012
   Google Scholar
• Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012;60(15):1438-54
   PubMed Web of Science ®Google Scholar
• Hayashida K, Lefevre T, Chevalier B, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv 2011;4(8):851-8
   PubMed Web of Science ®Google Scholar
• Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol 2012;59(2):113-18
   PubMed Web of Science ®Google Scholar
• Nakamura M, Chakravarty T, Jilaihawi H, et al. Complete percutaneous approach for arterial access in transfemoral transcatheter aortic valve replacement - A comparison with surgical cutdown and closure. Catheter Cardiovasc Interv 2014;84(2):293-300
   PubMed Web of Science ®Google Scholar
• Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364(23):2187-98
   PubMed Web of Science ®Google Scholar
• Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55(11):1080-90
   PubMed Web of Science ®Google Scholar
• Eggebrecht H, Schmermund A, Voigtlander T, et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 2012;8(1):129-38
   PubMed Web of Science ®Google Scholar
• Fairbairn TA, Mather AN, Bijsterveld P, et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart 2012;98(1):18-23
   PubMed Web of Science ®Google Scholar
• Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 2010;121(7):870-8
   PubMed Web of Science ®Google Scholar
• Hauville C, Ben-Dor I, Lindsay J, et al. Clinical and silent stroke following aortic valve surgery and transcatheter aortic valve implantation. Cardiovasc Revasc Med 2012;13(2):133-40
   Google Scholar
• Nuis RJ, Van Mieghem NM, Schultz CJ, et al. Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am J Cardiol 2012;109(11):1637-43
   PubMed Web of Science ®Google Scholar
• Amat-Santos IJ, Rodes-Cabau J, Urena M, et al. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol 2012;59(2):178-88
   PubMed Web of Science ®Google Scholar
• Kahlert P, Al-Rashid F, Dottger P, et al. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation 2012;126(10):1245-55
   PubMed Web of Science ®Google Scholar
• Naber CK, Ghanem A, Abizaid AA, et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention 2012;8(1):43-50
   PubMed Web of Science ®Google Scholar
• Nietlispach F, Wijesinghe N, Gurvitch R, et al. An embolic deflection device for aortic valve interventions. JACC Cardiovasc Interv 2010;3(11):1133-8
   PubMed Web of Science ®Google Scholar
• Rodes-Cabau J, Dauerman HL, Cohen MG, et al. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. J Am Coll Cardiol 2013;62(25):2349-59
   Google Scholar
• Dvir D, Barbash IM, Ben-Dor I, et al. Paravalvular regurgitation after transcatheter aortic valve replacement: diagnosis, clinical outcome, preventive and therapeutic strategies. Cardiovasc Revasc Med 2013;14(3):174-81
   PubMedGoogle Scholar
• Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol 2013;61(15):1585-95
   PubMed Web of Science ®Google Scholar
• Gurvitch R, Wood DA, Tay EL, et al. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation 2010;122(13):1319-27
   PubMed Web of Science ®Google Scholar
• Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011;58(20):2130-8
   PubMed Web of Science ®Google Scholar
• Barbanti M, Yang TH, Rodes Cabau J, et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation 2013;128(3):244-53
   PubMed Web of Science ®Google Scholar
• Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol 2013;62(17):1552-62
   PubMed Web of Science ®Google Scholar
• Erkapic D, De Rosa S, Kelava A, et al. Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol 2012;23(4):391-7
   PubMed Web of Science ®Google Scholar
• Bagur R, Webb JG, Nietlispach F, et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 2010;31(7):865-74
   PubMed Web of Science ®Google Scholar
• Pibaro P. Reduced incidence of prosthesis-patient mismatch and its sequelae in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis. In: ACC. San-Francisco, USA; 2013
   Google Scholar
• Simons CT, Cipriano LE, Shah RU, et al. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes 2013;6(4):419-28
   Google Scholar
• Reynolds MR, Magnuson EA, Lei Y, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol 2012;60(25):2683-92
   PubMed Web of Science ®Google Scholar
• Li X, Kong M, Jiang D, Dong A. Comparison 30-day clinical complications between transfemoral versus transapical aortic valve replacement for aortic stenosis: a meta-analysis review. J Cardiothorac Surg 2013;8:168
   PubMed Web of Science ®Google Scholar
• Di Mario C, Eltchaninoff H, Moat N, et al. The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients. EuroIntervention 2013;8(12):1362-71
   PubMed Web of Science ®Google Scholar
• Dvir D, Webb J, Brecker S, et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation 2012;126(19):2335-44
   PubMed Web of Science ®Google Scholar
• Chieffo A, Buchanan GL, Van Mieghem NM, et al. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration). J Am Coll Cardiol 2013;61(8):830-6
   PubMed Web of Science ®Google Scholar
• Buchanan G, Chieffo A, Montorfano M, et al. Transcatheter aortic valve implantation with Edwards SAPIEN XT™ versus Medtronic CoreValve Revalving System® with AccuTrak™: The SAPERE pilot study. In: The transcatheter cardiovascular therapeutics (TCT) conference. Miami, FL, USA;2012
   Google Scholar
• Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 2014;311(15):1503-14
   PubMed Web of Science ®Google Scholar